Comparison of essential medicines lists in 137 countries.

Comparison of essential medicines lists in 137 countries.

<p>Objective:To compare the medicines included in national essential medicines lists with the World Health Organization's (WHO's) Model list of essential medicines, and assess the extent to which countries' characteristics, such as WHO region, size and health care expenditure,...

Bibliografske podrobnosti
Main Authors:	Persaud, N, Jiang, M, Shaikh, R, Bali, A, Oronsaye, E, Woods, H, Drozdzal, G, Rajakulasingam, Y, Maraj, D, Wadhawan, S, Umali, N, Wang, R, McCall, M, Aronson, J, Plüddemann, A, Moja, L, Magrini, N, Heneghan, C
Format:	Journal article
Jezik:	English
Izdano:	World Health Organisation 2019

Podobne knjige/članki

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
od: Richards, GC, et al.
Izdano: (2020)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
od: Jordan D Jarvis, et al.
Izdano: (2019-01-01)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
od: Carl Heneghan, et al.
Izdano: (2020-11-01)

Withdrawn medicines included in the essential medicines lists of 136 countries.
od: Onella Charles, et al.
Izdano: (2019-01-01)

A comparison of national essential medicines lists in the Americas
od: Liane Steiner, et al.
Izdano: (2020-01-01)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
od: Darshanand Maraj, et al.
Izdano: (2022-05-01)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
od: Benedikt Huttner, et al.
Izdano: (2022-02-01)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
od: Bernadette Cappello, et al.
Izdano: (2020-09-01)

Integrated Diagnosis in Africa’s Low- and Middle-Income Countries: What Is It, What Works, and for Whom? A Realist Synthesis
od: Gamuchirai Gwaza, et al.
Izdano: (2024-09-01)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
od: Muhamad Z. Ally, et al.
Izdano: (2020-05-01)

Ten essential papers for the practice of evidence-based medicine
od: Nunan, D, et al.
Izdano: (2017)

Associations between essential medicines and health outcomes for cardiovascular disease
od: Liane Steiner, et al.
Izdano: (2021-03-01)

Essential cancer medicines and cancer outcomes: Cross‐sectional study of 124 countries
od: Oghenefejiro (Theresa) Ikpeni, et al.
Izdano: (2023-11-01)

Święty Augustyn, List do Woluzjana (Epistula 137)
od: Andrzej P. Stefańczyk
Izdano: (2010-07-01)

Biologic medicine inclusion in 138 national essential medicines lists
od: Raphaël Kraus, et al.
Izdano: (2021-09-01)

A word about evidence: ‘rapid reviews’ or ‘restricted reviews’?
od: Aronson, J, et al.
Izdano: (2018)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
od: Nav Persaud, et al.
Izdano: (2021-08-01)

Overview of systematic reviews: yoga as a therapeutic intervention for adults with acute and chronic health conditions.
od: McCall, M, et al.
Izdano: (2013)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
od: Plüddemann, A, et al.
Izdano: (2018)

Tough decisions on essential medicines in 2015
od: Nicola Magrini, et al.

Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes
od: Camila Heredia, et al.
Izdano: (2025-01-01)

Endocrinology and the essential list
od: Sanjay Kalra, et al.
Izdano: (2012-01-01)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
od: Jennifer Walsh, et al.
Izdano: (2022-02-01)

Characteristics and efficacy of digital health education: An overview of systematic reviews
od: McCall, M, et al.
Izdano: (2018)

Transvaginal mesh failure: lessons for regulation of implantable devices.
od: Heneghan, C, et al.
Izdano: (2017)

Sodium efflux and essential hypertension.
od: Boon, N, et al.
Izdano: (1982)

Seasonal dynamic of content of 137Cs in mushrooms
od: N. E. Zarubina
Izdano: (2007-03-01)

On Essentiality and the World Health Organization's Model List of Essential Medicines
od: Victoria A. Marks, et al.
Izdano: (2017-06-01)

Catalogue of bias: novelty bias
od: Luo, Y, et al.
Izdano: (2023)

Editorial No. 137
od: El Editor
Izdano: (2017-02-01)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
od: Heneghan, C, et al.
Izdano: (2017)

101 essential lists on assessment /
od: 464989 Rayment, Tabatha
Izdano: (2006)

Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy
od: Shirin Torkestani, et al.
Izdano: (2023-03-01)

Accuracy of self-diagnosis in conditions commonly managed in primary care: diagnostic accuracy systematic review and meta-analysis
od: McLellan, JH, et al.
Izdano: (2023)

Desorption of 137Cs+ from mosses
od: Dragović Snežana D., et al.
Izdano: (2002-01-01)

Kinetics of 137Cs distribution in fish organism
od: V. V. Belyaev, et al.
Izdano: (2006-06-01)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
od: Asma Abubakr Mustafa, et al.
Izdano: (2010-12-01)

The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA.
od: McCall, M, et al.
Izdano: (1986)

137Cesium (137Cs) assessment in wild boars from northwestern Italy.
od: Daniele Pattono, et al.
Izdano: (2024-01-01)

137Cesium (137Cs) assessment in wild boars from northwestern Italy
od: Daniele Pattono, et al.
Izdano: (2024-01-01)